Endocrine Abstracts

The twin epidemics of obesity and type 2 diabetes represent a major challenge to healthcare service provision worldwide. It has long been recognised that, while surgery is effective in treating both conditions, only a tiny proportion of patients who might be eligible can access appropriate services and even fewer actually undergo treatment. Furthermore, there exists a significant treatment gap on the continuum of risk:efficacy between diet and lifestyle and surgical interventions. A panel of endoscopic metabolic therapies show increasing promise in bridging this gap safely and effectively. The American Society of Gastrointestinal Endoscopy has ratified a number of these interventions as effective, in the setting of a multidisciplinary service. Dr Hayee will summarise the clinical landscape in endoscopic therapies and current areas of interest, focussing on those currently available as well as areas of research and development.